Free: What kind of tired are you? Take the 60-second quiz →

"Research Use Only": What It Means and Why It Matters

Three words most people skip on a label, what they really mean, and what did (and didn't) change for peptides in 2026.

By Ashley BrooksAugust 28, 20263 min readLast updated October 28, 2026
"Research Use Only": What It Means and Why It Matters

Maybe you've seen it in small print on a peptide website, or in one of our guides: "research use only." Most people skip right past those three words. Let's read them together, in plain words, and then look at what really changed in 2026.

What "Research Use Only" Means

Good sellers also keep the label honest. A seller that marks something "for research" and then tells you how to use it on yourself is, in the FDA's eyes, marketing an unapproved drug, and the agency has sent warning letters to sellers who did exactly that. One, in 2023, went to a company whose BPC-157 and TB-500, among other products, were labeled for "research purpose only" while its website made health claims and listed doses for people. FDA has also warned companies selling GLP-1 weight-loss drugs "falsely labeled 'for research purposes.'" The ones worth trusting sell for research and leave the medical advice to your doctor.

What Changed in 2026, and What Didn't

Compounding pharmacies make custom medicines from a doctor's prescription. Before 2026, FDA had put BPC-157, TB-500 and more than a dozen other peptides on its list of compounding ingredients that "may present significant safety risks." Its concerns included possible immune reactions, impurities and too little safety information in people. A pharmacy that compounded them could face FDA action.

In 2026, things started to move. In April, BPC-157, TB-500 and many of the others came off that list, but only because the groups that had nominated them for compounding withdrew their nominations. That didn't clear them for pharmacies to use. In July, an FDA advisory committee reviewed seven of them for possible use by compounding pharmacies: BPC-157, TB-500, KPV, MOTS-c, DSIP, Epitalon and Semax.

FDA's own staff recommended against adding any of the seven. According to news reports, the committee's outside advisers disagreed on most of them: in close votes, they recommended six of the seven, all but DSIP. Those votes are advice only. In late October, HHS then announced a draft "interim" policy: while FDA works on the official list through rulemaking, HHS says it does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician that compounds with the peptides named in an appendix to the policy. (News reports say that appendix covers six of the seven, again all but DSIP.) The notice asks for public comments for two weeks after it is published, and HHS says it may revisit the policy, for example if a safety signal or product quality problem turns up. None of the seven is on FDA's official list of ingredients pharmacies may use yet, none is an FDA-approved drug, and HHS notes that compounded drugs aren't FDA-approved, so FDA doesn't review their safety, effectiveness or quality before they're sold. So it's real movement, but it isn't an approval. We'll keep this page updated as it happens.

The Mom-Specific Part

A pregnant mother rests a hand on her belly by the window while her toddler plays with blocks.

This blog is for mothers, so here's the one thing we'll always tell you. If you're pregnant, could become pregnant, or are nursing, this is the season to wait. We couldn't find a single study that gave research peptides to pregnant or breastfeeding women. When FDA reviewed those seven peptides in 2026, it found almost no reproductive safety testing, even in animals: none for six of them, and one limited rat study for BPC-157. Even the labels for approved semaglutide (Ozempic and Wegovy) say to stop it at least two months before a planned pregnancy. When that season is over, your doctor can help you decide what fits.

Why the Excitement Makes Sense

Plenty of women are frustrated that peptides they keep hearing about sit in research for years while the system catches up. That frustration makes sense: the headlines sound exciting, and waiting is hard. But the slow part is also the part that protects you. It's where someone checks whether a peptide works, whether it's safe, and exactly what's in it. When FDA's staff reviewed those seven peptides in 2026, they found gaps on all three.

So if you're curious, keep your doctor in the loop, and bring two questions to your next visit: Is there an approved medicine for what I'm hoping a peptide would help with? And is there any reason I shouldn't try one?

Where That Leaves You

A mother holding her sleeping toddler talks with her doctor, who listens closely.

The last question in our guide to spotting health hype still holds: the best sources are happy to say "ask your doctor." Use that test on everyone who talks to you about peptides, including us.

This article is education, not medical advice. Talk to your doctor before starting, stopping, or changing anything.

Read next: Postpartum Hair Loss and Skin Changes: What's Normal and What's Not

Sources & references (13)

  1. FDA Warning Letter to Warrior Labz SARMS (MARCS-CMS 655280), June 12, 2023 (covers SARMs, BPC-157, TB-500 and other products labeled "research purpose only") — U.S. Food and Drug Administration, 2023
  2. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of October 1, 2026) — U.S. Food and Drug Administration, 2026
  3. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (content current as of April 22, 2026) — U.S. Food and Drug Administration, 2026
  4. Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act (content current as of May 14, 2026) — U.S. Food and Drug Administration, 2026
  5. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the FD&C Act (categories 1, 2 and 3), updated May 14, 2026 — U.S. Food and Drug Administration, 2026
  6. July 23-24, 2026 Meeting of the Pharmacy Compounding Advisory Committee: agenda and FDA briefing documents for all seven peptides — U.S. Food and Drug Administration, 2026
  7. FDA Briefing Document, Pharmacy Compounding Advisory Committee Meeting, July 23-24, 2026: Introduction (FDA's proposals for all seven peptides) — U.S. Food and Drug Administration, 2026
  8. FDA Briefing Document, Pharmacy Compounding Advisory Committee Meeting, July 23-24, 2026: BPC-157-Related Bulk Drug Substances (Docket FDA-2025-N-6895) — U.S. Food and Drug Administration, 2026
  9. Steinzor P. "FDA Panel Backs 6 Peptides for Compounding." AJMC, July 31, 2026 (source for the committee's votes; FDA has not posted meeting minutes) — AJMC (news report), 2026
  10. U.S. Department of Health and Human Services. "Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances." Notice of availability, Docket No. HHS-OASH-2026-0496, filed October 28, 2026 (FR Doc. 2026-22192). — U.S. Department of Health and Human Services (Federal Register), 2026
  11. 21 CFR 216.23: Bulk drug substances that can be used to compound drug products in accordance with section 503A (the 503A Bulks List) — Electronic Code of Federal Regulations, 2026
  12. WEGOVY (semaglutide) Prescribing Information, Novo Nordisk, revised June 2026 (sections 8.1 to 8.3: pregnancy, lactation, planned pregnancy) — U.S. National Library of Medicine (DailyMed), 2026
  13. OZEMPIC (semaglutide) Prescribing Information, Novo Nordisk, revised May 2026 (sections 8.1 to 8.3: pregnancy, lactation, planned pregnancy) — U.S. National Library of Medicine (DailyMed), 2026

This article is education, not medical advice. If you're struggling, call or text 988, or call Postpartum Support International at 1-800-944-4773.

Free · 60-second quiz

Which peptide guide is yours?

Five quick questions, and we'll point you to the guides that fit what you want help with.

  • Your mom type, and what it says about you
  • Three articles picked for your answers
  • Emails that fit your life, not everyone's
Question 1 of 5

How old is your youngest?

Free · about 60 seconds. Your results come by email right away, then a short email every few days, then the Sunday Letter. Unsubscribe anytime.

More in The Series

Discussion

Sign in or create an account to join the discussion.

Loading comments…